<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>KLOTHO NEUROSCIENCES RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Tue, 07 Apr 2026 05:03:02 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/klotho%5Fneurosciences%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>KLOTHO NEUROSCIENCES RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Klotho Neurosciences zog Bilanz zum jüngsten Jahresviertel</title><pubDate>Fri, 03 Apr 2026 06:35:06 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-zog-bilanz-zum-juengsten-jahresviertel-15593444</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/klotho_neurosciences-aktie">Klotho Neurosciences</a> hat am 01.04.2026 in der Finanzkonferenz die Quartalszahlen zum jüngsten Jahresviertel – Abschlussdatum 31.12.2025 – vorgestellt.Klotho Neurosciences hat im jüngsten Jahresviertel einen  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-zog-bilanz-zum-juengsten-jahresviertel-15593444</guid></item><item><title>Klotho Neurosciences to Present at the Biotech Showcase 2026</title><pubDate>Thu, 08 Jan 2026 14:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-to-present-at-the-biotech-showcase-2026-15402003</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Jan. 8, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company"),  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-to-present-at-the-biotech-showcase-2026-15402003</guid></item><item><title>Klotho Neurosciences stellte Ergebnisse des abgelaufenen Quartals vor</title><pubDate>Sat, 15 Nov 2025 06:35:06 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-stellte-ergebnisse-des-abgelaufenen-quartals-vor-15279401</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/klotho_neurosciences-aktie">Klotho Neurosciences</a> hat am 13.11.2025 das Zahlenwerk zum am 30.09.2025 ausgelaufenen Quartal vorgelegt.Dabei wurde ein Verlust je Aktie von 0,05 USD ausgewiesen. Im Vorjahresquartal waren -0,180 USD je  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-stellte-ergebnisse-des-abgelaufenen-quartals-vor-15279401</guid></item><item><title>Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award</title><pubDate>Fri, 07 Nov 2025 16:03:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-wins-the-2025-biotech-breakthrough-cell-therapy-innovation-of-the-year-award-15221192</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Nov. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ) (the "Company" or "Klotho"),  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-wins-the-2025-biotech-breakthrough-cell-therapy-innovation-of-the-year-award-15221192</guid></item><item><title>Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston</title><pubDate>Thu, 16 Oct 2025 14:00:00 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-ceo-to-attend-longevity-biotech-2025-in-boston-15079299</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Oct. 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company")  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-ceo-to-attend-longevity-biotech-2025-in-boston-15079299</guid></item><item><title>Klotho Neurosciences Announces Expiration of Letter of Intent</title><pubDate>Wed, 08 Oct 2025 00:20:00 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-announces-expiration-of-letter-of-intent-14966048</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company")  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/klotho-neurosciences-announces-expiration-of-letter-of-intent-14966048</guid></item></channel></rss>
